ChristianTRuffMD

Cardiovascular Disease Genetics

Director of General Cardiology, Brigham and Women's Hospital; Senior Investigator, TIMI Study Group; Associate Professor of Medicine, Harvard Medical School

Join to view full profile

Dr. Ruff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ruff's full profile

Already have an account?

Office
75 Francis St
Brigham & Women's Hospital
Boston, MA 02115
Phone+1 617-732-6660

Education & Training

Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2006 - 2009
Brigham and Women's HospitalResidency, Internal Medicine, 2003 - 2006
Johns Hopkins University School of MedicineClass of 2003

Certifications & Licensure

MA State Medical License 2005 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Publications & Presentations

PubMed

1 citations
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation.
Lars Wallentin, Johan Lindbäck, Ziad Hijazi, Jonas Oldgren, Anthony P Carnicelli
Journal of the American College of Cardiology. 2025-03-25
Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes.
Albert Henry, Xiaodong Mo, Chris Finan, Mark D Chaffin, Doug Speed
Nature Genetics. 2025-03-04
Endothelial cell-related genetic variants identify LDL cholesterol-sensitive individuals who derive greater benefit from aggressive lipid lowering.
Nicholas A Marston, Frederick K Kamanu, Giorgio E M Melloni, Gavin Schnitzler, Aaron Hakim
Nature Medicine. 2025-03-01

Journal Articles

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Stephen D Wiviott, Marc S Sabatine, Christian T Ruff, Marc P Bonaca, Deepak L Bhatt, Darren K McGuire, The New England Journal of Medicine
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Erin A Bohula, Stephen D Wiviott, Benjamin M Scirica, Darren K McGuire, Marc S Sabatine, Marc P Bonaca, Christian T Ruff, Silvio E Inzucchi, The New England Journal of Medicine

Lectures

Anticoagulation
2019 ACP Internal Medicine Meeting, Philadelphia - 4/13/2019
Debate: Patient With AF and Atherosclerosis Both an Antiplatelet and Anticoagulant are Needed
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Press Mentions

Study Demonstrates Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age, Bleeding RiskMarch 31st, 2025
Study Shows Abelacimab Significantly Reduced Bleeding vs. Standard DOACJanuary 24th, 2025
Fewer Bleeding Events Seen with Abelacimab Than Rivaroxaban in a-fibJanuary 24th, 2025
Join now to see all